Abstract. Prolonged survival in patients suffering from colorectal cancer (CRC) may lead to the emergence of rare metastatic sites that are not well-documented in the literature. We herein describe a very rare case of an intraluminal small intestinal metastasis in a patient with previously resected CRC. A 71-year-old Caucasian male patient with a history of rectosigmoid junction cancer was initially treated with anterior resection. The tumor was classified as pT3pN0 (0/26) M0, stage II. Eighteen months after the primary surgery, local recurrence was detected in the presacral region, and the patient received combined image-guided radiotherapy and chemotherapy. Two months later, due to residual disease at the level of the anastomosis, the patient underwent additional low anterior resection with a diverting stoma. During extensive adhesiolysis, a small palpable intraluminal mass was identified in the jejunum, and segmental small bowel resection was performed. Pathological examination of the resected specimen confirmed that the lesion was a metastasis from the CRC primary. The precise mechanism and clinical significance of CRC metastasis to the small bowel remain unclear. There is limited clinical experience with this condition, as <20 cases have been reported in the literature to date. The main symptoms leading to evaluation, diagnosis and surgical resection are bowel obstruction and bleeding. The present case highlights the possibility of uncomplicated presence of metastatic CRC in the small bowel. Therefore, dilligent inspection of the peritoneal cavity, including the entire length of the gastrointestinal canal, is of paramount importance, particularly in cases of recurrent CRC.
IntroductionColorectal cancer (CRC) constitutes a considerable cause of morbidity and mortality worldwide, representing the 3rd leading cause of cancer-related mortality in the USA (1). Approximately 135,000 new cases are diagnosed in USA annually, whereas ~50,000 CRC-related patient deaths are expected per year (1). Over half of the patients with CRC will develop metastases during their lifespan. The most common sites of CRC metastases include the liver, lung and peritoneum; however, various other metastatic sites, such as the bones, spleen, brain and distant lymph nodes, have also been described.Several improvements and strategic adjustments in the management of patients with metastatic CRC have subsequently led to remarkably improved outcomes (2). Changes in the clinical presentation of the patients, ameliorated preoperative assessment, tailored surgical resection, closer postoperative follow-up and advances in chemotherapeutic regimens represent some of these improvements, which have allowed for expansion of life expectancy in these patients (2). As a consequence, prolonged survival divulges rare metastatic sites that are not well-documented in the literature; the assessment and relevant results from the surgical management of these rare metastatic sites remain ill-reported. We herein describe a very rare case of small intestinal intr...